Clinical Trials Directory

Trials / Unknown

UnknownNCT05764850

Mechanisms of Type 1 Diabetes Endophenotypes

Mechanisms of Type 1 Diabetes Endophenotypes, by Cluster Analysis

Status
Unknown
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Pediatric Clinical Research Platform · Academic / Other
Sex
All
Age
0 Years – 25 Years
Healthy volunteers
Accepted

Summary

The goal of this observational study consists of performing cluster analysis to decipher underlying disease mechanisms of type 1 diabetes in children and young adults. To this end, we will combine clinical, laboratory, genetic, transcriptomic, and metabolomic datasets of an extensively phenotyped cohort of children and young adults with type 1 diabetes. We will also assess the risk for cardiovascular diseases in this most vulnerable diabetes cohort.

Conditions

Interventions

TypeNameDescription
GENETICGenome sequencing100 extensively phenotyped pediatric and young adult patients for genotyping, metabolomic and lipidomic analyses. Polygenic risk scores for type 1 diabetes and cardiovascular disease will be performed. For patients older than 6 years who agree to do a second visit (optional), a Mixed Meal Tolerance Test (MMTT: the gold standard for assessing beta cell function) will be done as well as transcriptomic analysis.

Timeline

Start date
2023-02-01
Primary completion
2026-02-01
Completion
2026-02-01
First posted
2023-03-13
Last updated
2023-03-13

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT05764850. Inclusion in this directory is not an endorsement.